Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities

The emergence and continuous development of immune checkpoint inhibitors (ICIs) therapy brings a revolution in cancer therapy history, but the major hurdle associated with their usage is the concomitant ICIs-related toxicities that present a challenge for oncologists. The toxicities may involve non-...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Xu, Ya, Fu, Yang, Zhu, Bo, Wang, Jun, Zhang, Bicheng
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572846/
https://ncbi.nlm.nih.gov/pubmed/33123120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.02023
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items